The data was included in the paper, titled “Sozinibercept Combination Therapy for Neovascular Age-Related Macular ...

A total of 43 patients who recovered from the SARS-CoV-2 infection with mild pneumonia were included along with 45 healthy individuals. Researchers from Istanbul, Turkey, conducted a study that found ...

Yu reviewed the benefits and limitations of various electrophysiologic technologies in a diverse group of inflammatory conditions affecting the retina and optic nerve. Ophthalmic electrophysiology is ...

This database could enhance the workflow of eye care professionals with its in-depth reference data for retinal layer thickness and optic nerve head metrics.

The findings were from 6 patients in the first low-dose cohort of the ongoing first-in-human trial (NCT04627428).

Yehia Hashad, MD, has been appointed to the board of directors and as a member of its science committee for Unity Biotechnology Inc. In the company’s press release 1, Anirvan Ghosh, PhD, chief ...

4D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) from the retina with a single, safe, intravitreal injection.

Physicians’ Education Resource (PER) has launched Retina Resource, a comprehensive source of education and information on the latest innovations in anti-VEGF therapy, tailored to retina specialists ...

Chinese investigators found that renal dysfunction is a risk factor associated with the efficacy of intravitreal conbercept (IVC) injections (Lumitin, Chengdu Kanghong Biotech Co., Ltd.) for treating ...

Pykus Therapeutics has secured a new patent from the United States Patent and Trademark Office entitled "Hydrogel Formulations and Methods and Devices for Administration of the Same" (US Patent No. 12 ...